Arun Samuga, chief technology officer at Elemica explains how blockchain can add value to the pharmaceutical industry.
Blockchain
The current health crisis affects all of us: It’s a global struggle that gives companies and producers in the pharmaceutical sector a special responsibility. Product availability, safety and credibility are the critical requirements for doctors, patients and producers of drugs and medical equipment these days.
Technology is proving to be an accelerant in the manufacturing and distribution of these products. It has a significant presence in both upstream and downstream manufacturing activities: data analysis and testing, innovation, quality, production, logistics, and administration. As we applaud these activities that will save lives, it is worthwhile to visit how emerging technologies, like blockchain, could add further value.